54 related articles for article (PubMed ID: 6299525)
1. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
Tucker RF; Volkenant ME; Branum EL; Moses HL
Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
[TBL] [Abstract][Full Text] [Related]
2. Role of transforming growth factor Beta in corneal function, biology and pathology.
Tandon A; Tovey JC; Sharma A; Gupta R; Mohan RR
Curr Mol Med; 2010 Aug; 10(6):565-78. PubMed ID: 20642439
[TBL] [Abstract][Full Text] [Related]
3. Ligand-mediated endocytosis and intracellular sequestration of guanylyl cyclase/natriuretic peptide receptors: role of GDAY motif.
Pandey KN
Mol Cell Biochem; 2010 Jan; 334(1-2):81-98. PubMed ID: 19941037
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell function.
Li XF; Takiuchi H; Zou JP; Katagiri T; Yamamoto N; Nagata T; Ono S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1993 Mar; 84(3):315-25. PubMed ID: 8098027
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of human colon carcinoma.
Brattain MG; Levine AE; Chakrabarty S; Yeoman LC; Willson JK; Long B
Cancer Metastasis Rev; 1984; 3(3):177-91. PubMed ID: 6437669
[TBL] [Abstract][Full Text] [Related]
6. Molecular lesions in cancer.
Busch H
Mol Cell Biochem; 1984; 61(2):111-30. PubMed ID: 6374426
[TBL] [Abstract][Full Text] [Related]
7. Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.
Tucker RF; Branum EL; Shipley GD; Ryan RJ; Moses HL
Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6757-61. PubMed ID: 6208555
[TBL] [Abstract][Full Text] [Related]
8. Onc genes and other new targets for cancer chemotherapy.
Busch H
J Cancer Res Clin Oncol; 1984; 107(1):1-14. PubMed ID: 6199358
[TBL] [Abstract][Full Text] [Related]
9. Growth control in cultured 3T3 fibroblasts. V. Purification of an Mr 13,000 polypeptide responsible for growth inhibitory activity.
Hsu YM; Wang JL
J Cell Biol; 1986 Feb; 102(2):362-9. PubMed ID: 3944188
[TBL] [Abstract][Full Text] [Related]
10. Type beta transforming growth factor: a bifunctional regulator of cellular growth.
Roberts AB; Anzano MA; Wakefield LM; Roche NS; Stern DF; Sporn MB
Proc Natl Acad Sci U S A; 1985 Jan; 82(1):119-23. PubMed ID: 3871521
[TBL] [Abstract][Full Text] [Related]
11. Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval.
Shipley GD; Tucker RF; Moses HL
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4147-51. PubMed ID: 3858871
[TBL] [Abstract][Full Text] [Related]
12. Modulation of transforming growth factor type beta action by activated ras and c-myc.
Leof EB; Proper JA; Moses HL
Mol Cell Biol; 1987 Jul; 7(7):2649-52. PubMed ID: 3475570
[TBL] [Abstract][Full Text] [Related]
13. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures.
Majack RA
J Cell Biol; 1987 Jul; 105(1):465-71. PubMed ID: 3475277
[TBL] [Abstract][Full Text] [Related]
14. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells.
Assoian RK; Sporn MB
J Cell Biol; 1986 Apr; 102(4):1217-23. PubMed ID: 3457014
[TBL] [Abstract][Full Text] [Related]
15. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family.
de Martin R; Haendler B; Hofer-Warbinek R; Gaugitsch H; Wrann M; Schlüsener H; Seifert JM; Bodmer S; Fontana A; Hofer E
EMBO J; 1987 Dec; 6(12):3673-7. PubMed ID: 3322813
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
Lyons RM; Keski-Oja J; Moses HL
J Cell Biol; 1988 May; 106(5):1659-65. PubMed ID: 2967299
[TBL] [Abstract][Full Text] [Related]
17. Role of a tumor-suppressor gene in the negative control of anchorage-independent growth of Syrian hamster cells.
Koi M; Afshari CA; Annab LA; Barrett JC
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8773-7. PubMed ID: 2813423
[TBL] [Abstract][Full Text] [Related]
18. Native and a synthetic analogue of the malignancy-associated parathyroid hormone-like protein have in vitro transforming growth factor-like properties.
Insogna KL; Stewart AF; Morris CA; Hough LM; Milstone LM; Centrella M
J Clin Invest; 1989 Mar; 83(3):1057-60. PubMed ID: 2537846
[TBL] [Abstract][Full Text] [Related]
19. Production of TGF-alpha and TGF-beta by cultured keratinocytes, skin and oral squamous cell carcinomas--potential autocrine regulation of normal and malignant epithelial cell proliferation.
Partridge M; Green MR; Langdon JD; Feldmann M
Br J Cancer; 1989 Oct; 60(4):542-8. PubMed ID: 2478181
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory action of transforming growth factor beta on endothelial cells.
Müller G; Behrens J; Nussbaumer U; Böhlen P; Birchmeier W
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5600-4. PubMed ID: 2441387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
